Title: THE BIOTECH INDUSTRY:
1THE BIOTECH INDUSTRY
Firms that produce, analyse, or use biological
systems on a micro-, cellular-, or molecular
level or firms that develops tools and supplies
for these purposes.
2The Swedish biotech industry
- Agrobiotechnology - plant improvement and
biological plant protection - Bioproduction - biomolecular or micro-organism
production - Biotech tools and supplies - services,
processes, equipment and instruments for
biotechnological use - Environmental biotechnology - soil, water, and
waste treatment - Functional food and feed - mainly probiotics
- Pharmaceuticals and medicine - drug discovery
and drug development, diagnostics and medical
technology
3Number of biotechnology companies in different
countries year 2000
Source The Swedish Trade council, Global
perspectives on bioscience 2002
4Number of companies and employees
5The regional distribution of the Swedish biotech
industry 1999
No. of employees
No. of companies
The sizes of the circles are proportional to
the number of employees/companies. Only micro-,
and small sized companies (lt200 employees) are
included. The distribution is based on the seat
of the county government.
6Number of companies
7Number of employees
8Turnover
9Number of companies pharmaceuticals medicine
10Number of employees in pharmaceuticals medicine
11Median equity/assets ratio
80
Finacial strength, median ()
Agrobiotechnology
70
Bioproduction
60
Biotech tools supplies
50
Environmental biotechnology
40
Functional food feed
30
Pharmaceuticals medicine
20
1997
1998
1999
2000
Year
12Net profits/losses in surviving companies in
the different biotech sectors, 1998 2001
13Share of surviving companies with net profit
1998-2001 in total and in each sector
14Size of sector in Sweden
- PHARMACEUTICALS AND MEDICAL TECHNOLOGY
- Approximately 30 000 employees and a turnover of
60 billion SEK - BIOTECHNOLOGY
- The fourth largest biotechnology industry in
Europe after - Great Britain, Germany, and France and the
ninth in the world - 183 SMEs (lt 500 emp. each), increase by 35
1997-2001 - About 4000 employees, increase by 48 1997-2001
- Turnover 4.4 billion SEK (2000), increase by 30
1997-2000 - Increased financial strength and net losses
1997-2001
European Commission Ernst Young The
Swedish Trade Council Fixed prices
15Reasons for the development
- UNTIL 1999
- The science base
- The presence of Astra and Pharmacia
- An internationally growing market
- Success stories inspires
- Changed attitudes
- Good availability of seed and venture capital
- CHANGE DURING 2000-20022003
- Development at the stock exchange
- Cautious venture capital companies
- Lack of seed capital
16The Swedish science base in international
comparison
- THE SWEDISH SCIENTIFIC PERFORMANCE IN GENERAL
- The trend is increased quantity but at the same
time there are - signs of decreasing quality.
- PERFORMANCE IN A SELECTION OF LIFE SCIENCE FIELDS
- First, second or third ranking of publication
volumes in relation to - population in the selected seven subject
fields. - Five out of seven fields showed increasing
shares of the worlds - total publication volume.
- Four out of seven fields showed increased
citation levels but - still Swedish citation levels are loosing
their top position
17Swedish ranking in relation to population
1986-2001
1986-1989 1990-1993 1994-1997 1998-2001 Total 87-01
Biochemistry Biophysics 2 2 2 2 2
Biotechnol Appl Microbiol 3 4 3 1 2
Cell Developmental Biol 3 3 2 2 2
Immunology 1 2 2 2 2
Microbiology 2 2 4 3 3
Molecular Biology Genetics 2 2 3 2 2
Neurosciences Behavior 1 1 1 1 1
18Relative citation levels in biochemistry and
biophysics
19Relative citation levels in neurosciences and
behavior
20Volume shares for the nine most productive
Swedish public research organisations of the
total Swedish publication volumein
biotechnology-related science, 1987-2001
21Co-authorship pattern between organisations with
the largest publication volumes in biotechnology
related science 1997-2001
22The Swedish percentage of the worlds total
publication volume within a selection of life
science fields during five periods (1987-2001)
23Relative citation levels for Swedish articles
within a selection of life science fields during
1987-1997 (Index world1)
24Inventor origin for biotechnology patents in the
US patent system 1987-2001
Sweden lt 1
25Swedish inventor shares of the worlds total
patenting volume during five periods in different
areas compared to the Swedish average share in
all fields 1987-2001
26Number of patents for Astra and Pharmacia